Deerfield Management’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-4,166
Closed -$758K 271
2024
Q3
$758K Buy
4,166
+2,561
+160% +$466K 0.01% 204
2024
Q2
$295K Buy
+1,605
New +$295K ﹤0.01% 347
2023
Q2
Sell
-311,949
Closed -$25M 106
2023
Q1
$25M Buy
311,949
+136,949
+78% +$11M 0.56% 47
2022
Q4
$13.9M Hold
175,000
0.29% 66
2022
Q3
$12.2M Buy
+175,000
New +$12.2M 0.24% 75